Last reviewed: June 8, 2026
Last updated: June 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists have become a leading treatment option for weight management, with clinical trials showing an average weight loss of 15-22% over 68 weeks. If you carry an HSA or FSA, you may be able to use these tax-advantaged funds to cover your GLP-1 therapy through PlexusDx, making precision weight loss treatment more financially accessible.
Are GLP-1 Medications HSA and FSA Eligible?
Yes—all GLP-1 medications offered by PlexusDx qualify for both Health Savings Account (HSA) and Flexible Spending Account (FSA) reimbursement. This includes compounded semaglutide injections, oral semaglutide, tirzepatide injections, and combination therapies like GLP-Squared. The Internal Revenue Service treats prescription weight loss medications as qualified medical expenses when prescribed by a licensed healthcare provider, which PlexusDx delivers through its telehealth platform.
Using an HSA or FSA for your GLP-1 therapy can reduce your effective out-of-pocket cost by 20-37%, depending on your tax bracket. PlexusDx compounded semaglutide starts at $149 per month, meaning HSA holders can redirect pre-tax income toward treatment without reducing take-home pay. No insurance is required, and there are no membership fees—making this pathway ideal for self-insured individuals or those with high deductible health plans (HDHPs).
How HSA and FSA Plans Work With PlexusDx Medications
An HSA is a savings account paired with a high-deductible health insurance plan, allowing you to contribute up to $4,150 annually (individual coverage in 2024) and carry unused funds year to year. An FSA is an employer-sponsored account with annual contribution limits up to $3,200 that typically requires you to spend funds within the plan year. Both account types let you pay for qualified medical expenses—including prescription medications—with pre-tax dollars, then request reimbursement or use a debit card linked to the account.
When you enroll in a PlexusDx GLP-1 program, your monthly medication cost is a direct qualified medical expense. You can pay out of pocket and request HSA/FSA reimbursement using invoices PlexusDx provides, or link your HSA/FSA debit card directly at checkout. This flexibility means your compounded semaglutide injection (starting at $149/month) or tirzepatide (starting at $249/month) can be funded entirely through tax-advantaged savings, preserving cash for other needs.
What Makes PlexusDx Medications Eligible for HSA/FSA Use
PlexusDx compounds all GLP-1 medications through licensed 503A compounding pharmacies, which are FDA-regulated facilities that can customize formulations under a valid prescription. These are not mass-manufactured drugs but rather medications prepared by licensed pharmacists specifically for your treatment plan. The IRS and health plan administrators recognize medications from regulated 503A compounders as legitimate prescription products, making them eligible for HSA and FSA reimbursement just like brand-name or generic alternatives.
Each PlexusDx order includes detailed invoices and prescription documentation that clearly identify the medication, dosage, prescriber, and pharmacy license number. You can submit these documents directly to your HSA or FSA administrator for reimbursement, or use a linked debit card at the point of purchase. PlexusDx also supports three commitment tiers (monthly, quarterly, and semi-annual), meaning you can budget HSA contributions around your preferred payment schedule without losing eligibility status.
Maximizing Your Tax Savings With GLP-1 Treatment
If you carry a high-deductible health plan (HDHP) and fund an HSA, GLP-1 medications represent one of the largest ongoing qualified medical expenses you can pay with pre-tax dollars. An individual in the 24% federal tax bracket who uses HSA funds for semaglutide (starting at $149/month or $1,788 annually) avoids approximately $429 in federal taxes per year. Over a three-year treatment window, that translates to over $1,200 in tax savings—money that stays in your health account or reduces your tax burden.
PlexusDx does not charge membership fees or insurance requirements, meaning HSA and FSA holders benefit from transparent, predictable monthly costs. The Precision Peptide Genetic Test ($99 after your first month of treatment) is also a qualified medical expense, allowing you to personalize your therapy using genetic insights into your GLP1R, GIPR, FTO, and MC4R pathways while preserving HSA funds. Bundle your genetic test with your monthly medication to maximize the value of your health savings account.
Step-by-Step Process for Using Your HSA or FSA at PlexusDx
Step 1: Enroll in a PlexusDx program by completing a telehealth consultation with a licensed provider. Your provider issues a prescription for compounded GLP-1 medication (semaglutide, tirzepatide, or a combination) tailored to your health profile. Step 2: At checkout, you can pay directly via credit card and request reimbursement from your HSA/FSA, or link your HSA/FSA debit card if your plan administrator permits point-of-sale purchases. PlexusDx accepts HSA/FSA debit cards that are configured for online transactions.
Step 3: Keep your itemized invoice and prescription documentation for your records and tax filing. If you paid out of pocket, submit these documents to your HSA or FSA administrator within the required timeframe (typically 60 days for FSAs; no deadline for HSAs). Step 4: Receive reimbursement from your health account. For ongoing monthly treatments, you can repeat this process each month or automate HSA/FSA debit card payments. PlexusDx customer support can clarify your plan's specific rules and help ensure documentation is complete before submission.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I pay for PlexusDx compounded semaglutide directly with my HSA debit card?
Yes, if your HSA or FSA debit card is enabled for online transactions and your plan administrator allows pharmacy purchases. You can link your card at PlexusDx checkout. If your card is restricted, you can pay out of pocket and submit an invoice for reimbursement. PlexusDx provides itemized documentation for all reimbursement requests.
Is the Precision Peptide Genetic Test covered by HSA or FSA funds?
Yes. The Precision Peptide Genetic Test ($99 add-on after your first month) qualifies as a medical expense under IRS guidelines because it is ordered by your PlexusDx provider to guide treatment decisions. You can pay for the test using HSA or FSA funds through the same process as your monthly medication.
What is the difference between a 503A compounded medication and a brand-name GLP-1 drug for HSA eligibility?
Both are eligible for HSA and FSA reimbursement when prescribed by a licensed provider. PlexusDx uses licensed 503A compounding pharmacies, which are FDA-regulated and produce medications from bulk pharmaceutical ingredients under strict quality controls. The key difference is customization: PlexusDx compounds can be tailored to your dosage and delivery method (injection or oral) based on your genetic predispositions and clinical needs.
Do I lose my HSA balance if I don't use it by the end of the year?
No—HSAs are different from FSAs. HSA balances carry over indefinitely, and unused funds remain available the following year. FSAs, however, typically operate on a "use-it-or-lose-it" basis unless your employer offers a grace period or carryover option. Check with your plan administrator for FSA rules. This makes HSAs ideal for ongoing GLP-1 therapy.
How much can I save using my HSA for GLP-1 medications each year?
Tax savings depend on your federal tax bracket. At a 24% federal rate, using your HSA to cover compounded semaglutide ($149/month = $1,788/year) saves approximately $429 in federal taxes annually. If your employer plan includes a state income tax deduction, savings may increase by an additional 5-10%. Over two to three years of treatment, tax savings typically range from $800 to $1,500.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Are Semaglutide Pills as Effective as Injections?
Lipo B for GLP-1 Stack — Mechanism, Timing & Results